MedImmune Overview

  • Founded
  • 1988
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 3,000
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 5
  • Investments
  • 20

MedImmune General Information

Description

Developer of drugs for prevention and treatment of infectious disease, autoimmune diseases and cancer. The company undertakes the research and development, manufacture and marketing of biologics to address some of the major medical needs in the healthcare industry.

Contact Information

Formerly Known As
Molecular Vaccines, Inc.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Parent Company
Primary Office
  • One MedImmune Way
  • Gaithersburg, MD 20878
  • United States
+1 (301) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MedImmune Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MedImmune‘s full profile, request access.

Request a free trial

MedImmune Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs for prevention and treatment of infectious disease, autoimmune diseases and cancer. The company under
Medical Supplies
Gaithersburg, MD
3,000 As of 2008
00.00 0000-00-00
000000&0

0000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000000 00000000
Emeryville, CA
0.000 0000-00-00
00000000000

000000

ommodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fu
0000000000000
Lexington, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MedImmune Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Grifols Diagnostic Solutions Corporate Backed or Acquired Emeryville, CA 00000000000
000000 Formerly VC-backed Lexington, MA 000 00000 000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

MedImmune Patents

MedImmune Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210213104-A1 Glucagon and glp-1 co-agonists for the treatment of chronic kidney disease and diabetic kidney disease in type 2 diabetes Pending 10-Jan-2020 000000000
GB-201917254-D0 Combination therapy Pending 27-Nov-2019 00000000000
US-20210121406-A1 Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof Pending 28-Oct-2019 0000000000
US-20210009671-A1 Compounds and methods for treating pain Pending 10-May-2019 000000000
US-20200317803-A1 Anti-cd73, anti-pd-l1 antibodies and chemotherapy for treating tumors Pending 02-Apr-2019 A61P35/00

MedImmune Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedImmune Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MedImmune‘s full profile, request access.

Request a free trial

MedImmune Investments & Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 25-Apr-2018 00000 00000 00 0000 Biotechnology
00000000 000000000 17-Feb-2016 00000 00000 00 000.00 Biotechnology
000000 000000 (000 10-Oct-2015 000000000 00000 00 00000 Buildings and Property 00000 000000000 00.0
000000000 25-Nov-2014 000000000000000000 00000 Distributors/Wholesale 000000 000000 00.0
Allozyne 01-Jan-2014 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 20 investments and acquisitions. Get the full list »

MedImmune Subsidiaries (3)

Company Name Industry Location Founded
MedImmune Ventures Corporate Venture Capital Gaithersburg, MD 2002
000000000 Acquirer Munich, Germany 0000
000000 Biotechnology Mountain View, CA 0000
To view MedImmune’s complete subsidiaries history, request access »

MedImmune Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 25-Apr-2018 00000 00000 00 0000 Completed
  • 10 buyers
00000000 000000000 17-Feb-2016 00000 00000 00 000.00 Completed
  • 5 buyers
000000 00000000000 01-May-2002 00000 00000 00 000 Completed
  • 000000000
0000000 000000000 15-Jun-2000 00000 00000 00 000.00 Completed
  • 7 buyers
Applied Molecular Evolution 11-Sep-1997 Later Stage VC 000 Completed
  • 6 buyers
You’re viewing 5 of 10 exits. Get the full list »